Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of 4-dose vs 1-dose Synflorix Presentation in Infants
NCT02447432Phase 3Completed
- Sponsor
- GSK
- Start
- Jun 2015
- Primary completion
- Jan 2016
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
A Phase 3 trial of 10-valent pneumococcal conjugate vaccine in pneumococcal disease, sponsored by GSK. Started Jun 2015; status: completed.
02
Drugs
10-valent pneumococcal conjugate vaccine
03
Conditions
pneumococcal disease
Beyond the preview
Go deeper on NCT02447432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02447432.